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Abstract
© 2017,  Nizhny  Novgorod  State  Medical  Academy.  All  rights  reserved.  The  aim  of  the
investigation was to assess the significance of the content of metabolites of the nitric oxide,
sICAM-1 and sICAM-3 in blood serum and in exhaled breath condensate, the serum level of
endothelin-1 as systemic and topical markers of inflammation in patients with COPD, and their
correlations with the parameters of lung ventilation function. Materials and methods. 91 patients
with COPD, aged from 46 to 67, and 21 healthy, non-smoking volunteers took part in the study.
The material for investigation was blood serum and exhaled breath condensate. Results. The
severity of progression of COPD was linked with an increase in the serum content of sCD50,
sCD54, ET-1, as well as in the concentrations of metabolites of nitric oxide in blood and in
exhaled  breath  condensate.  For  the  patients  with  COPD  we  determined  the  associations
between the function of pulmonary ventilation and the levels of ET-1, sICAM-1, sICAM-3 and the
value of ΣNO – 2 /NO – 3 . The resulting correlations between the concentration of soluble
adhesion molecules,  the values of  nitrosative stress,  and ET-1 level  indicate that they are
involved in the genesis of chronic inflammation in COPD patients.
http://dx.doi.org/10.17691/stm2017.9.2.13
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